These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 10583313

  • 21. The effect of thyroid status on the growth hormone response to growth hormone releasing hormone 1-44.
    Davies RR, Dagogo-Jack S, Turner SJ, Kendall-Taylor P, Baylis P, Young E, Watson M, Johnston DG.
    J Endocrinol Invest; 1989 Sep; 12(8):517-21. PubMed ID: 2512339
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effect of somatostatin infusion on the somatotrope responsiveness to growth hormone-releasing hormone in patients with anorexia nervosa.
    Gianotti L, Rolla M, Arvat E, Belliti D, Valetto MR, Ferdeghini M, Ghigo E, Müller EE.
    Biol Psychiatry; 1999 Feb 01; 45(3):334-9. PubMed ID: 10023511
    [Abstract] [Full Text] [Related]

  • 24. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML, Kaiser DL, Martha PM, Furlanetto R, Rivier J, Vale W, Thorner MO.
    J Clin Endocrinol Metab; 1989 Jan 01; 68(1):22-8. PubMed ID: 2491864
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Provocative hypothalamopituitary axis tests in severe head injury: correlations with severity and prognosis.
    Della Corte F, Mancini A, Valle D, Gallizzi F, Carducci P, Mignani V, De Marinis L.
    Crit Care Med; 1998 Aug 01; 26(8):1419-26. PubMed ID: 9710103
    [Abstract] [Full Text] [Related]

  • 29. Serum thyroxine and triiodothyronine responses of hyperthyroid cats to thyrotropin.
    Mooney CT, Thoday KL, Doxey DL.
    Am J Vet Res; 1996 Jul 01; 57(7):987-91. PubMed ID: 8807008
    [Abstract] [Full Text] [Related]

  • 30. Effect of pyridostigmine and pirenzepine on GH responses to GHRH in hyperthyroid patients.
    Valcavi R, Dieguez C, Zini M, Page MD, Dotti C, Portioli I, Scanlon MF.
    Clin Endocrinol (Oxf); 1991 Aug 01; 35(2):141-4. PubMed ID: 1934529
    [Abstract] [Full Text] [Related]

  • 31. The effect of iopanoic acid on the regulation of thyrotropin secretion in euthyroid subjects.
    Kleinmann RE, Vagenakis AG, Braverman LE.
    J Clin Endocrinol Metab; 1980 Aug 01; 51(2):399-403. PubMed ID: 6772664
    [Abstract] [Full Text] [Related]

  • 32. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism.
    Borges MH, DiNinno FB, Lengyel AM.
    Clin Endocrinol (Oxf); 1997 Jun 01; 46(6):713-8. PubMed ID: 9274702
    [Abstract] [Full Text] [Related]

  • 33. Impaired GH secretion to provocative stimuli in two families with hypocalciuric hypercalcaemia.
    Cecconi E, Bogazzi F, Cetani F, Grasso L, Marcocci C, Genovesi M, Procopio M, Gasperi M, Pinchera A, Ghigo E, Martino E.
    Clin Endocrinol (Oxf); 2003 Nov 01; 59(5):604-6. PubMed ID: 14616884
    [Abstract] [Full Text] [Related]

  • 34. Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.
    Popovic V, Simic M, Ilic L, Micic D, Damjanovic S, Djurovic M, Obradovic S, Dieguez C, Casanueva F.
    Clin Endocrinol (Oxf); 1998 Jan 01; 48(1):103-8. PubMed ID: 9509075
    [Abstract] [Full Text] [Related]

  • 35. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome.
    Leal-Cerro A, Pumar A, Garcia-Garcia E, Dieguez C, Casanueva FF.
    Clin Endocrinol (Oxf); 1994 Nov 01; 41(5):649-54. PubMed ID: 7828354
    [Abstract] [Full Text] [Related]

  • 36. Effect of digoxin on the somatotroph responsiveness to growth hormone-releasing hormone (GHRH) alone or combined with arginine in normal young volunteers.
    Broglio F, Benso A, Gottero C, Vito LD, Granata R, Arvat E, Bobbio M, Trevi G, Ghigo E.
    Clin Endocrinol (Oxf); 2001 Dec 01; 55(6):755-8. PubMed ID: 11895217
    [Abstract] [Full Text] [Related]

  • 37. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients.
    Cordido F, Peñalva A, Martinez T, Casanueva FF, Dieguez C.
    Clin Endocrinol (Oxf); 2001 Apr 01; 54(4):509-13. PubMed ID: 11318787
    [Abstract] [Full Text] [Related]

  • 38. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
    Cordido F, Fernandez T, Martinez T, Peñalva A, Peinó R, Casanueva FF, Dieguez C.
    J Clin Endocrinol Metab; 1998 Dec 01; 83(12):4350-4. PubMed ID: 9851776
    [Abstract] [Full Text] [Related]

  • 39. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
    Popovic V, Micic D, Djurovic M, Obradovic S, Casanueva FF, Dieguez C.
    Clin Endocrinol (Oxf); 1997 May 01; 46(5):539-43. PubMed ID: 9231048
    [Abstract] [Full Text] [Related]

  • 40. Effects of fasting and pegvisomant on the GH-releasing hormone and GH-releasing peptide-6 stimulated growth hormone secretion.
    Muller AF, Janssen JA, Lamberts SW, Bidlingmaier M, Strasburger CJ, Hofland L, van der Lely AJ.
    Clin Endocrinol (Oxf); 2001 Oct 01; 55(4):461-7. PubMed ID: 11678828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.